SBI CONTRA Fund

SBI Contra Fund has delivered strong long-term SIP XIRR of 19.997% over 10 years and 18.37% over 5 years, broadly in line with or slightly below category averages (18.97% and 18.12% respectively). Against the NIFTY 50, the fund shows consistent alpha across all periods, including 9.36% over 5 years and 11.42% over 7 years, with lump-sum CAGRs of 17.02% and 22.37% versus the benchmark's 7.89% and 11.9%. Recent 1-year SIP XIRR of 20.74% trails the category average of 21.07% marginally.

The fund exhibits a defensive risk profile with a beta of roughly 0.83-0.88 and downside capture of 75-83% across periods, meaning it falls meaningfully less than the NIFTY 50 in corrections. Upside capture of 87-90% combined with lower downside capture underpins its positive alpha and favorable risk-adjusted returns, reflected in stable Calmar ratios of 0.37-0.44. However, the maximum drawdown lasted 790 days with a 254-day recovery, and six drawdown events exceeding 10% indicate extended recovery periods that investors must be prepared to endure.

The portfolio is well diversified across 81 holdings, with the top position at just 4.8% (Reliance Industries) and the top 10 totaling about 31.5% of NAV. Banks dominate at 19.3% of the portfolio, followed by Pharmaceuticals at 7.1% and Petroleum Products at 5.8%, giving a value-oriented tilt consistent with the contra mandate. Exposure spans financials, energy, power, telecom, and healthcare, providing reasonable sector diversification despite the banking overweight.

The fund's SIP XIRR is essentially at par with the category over 3 years (18.10% vs 18.09%) and 12 years (18.61% vs 18.26%), though it lags slightly over 5, 7, and 10 years. Its standout feature versus peers is the consistent alpha over the NIFTY 50 across every measured window from 1 to 15 years, supported by disciplined downside protection. Calendar year returns show strong upside years (50.3% in 2021, 48.3% in 2014) but also meaningful down years (-13.55% in 2018), indicating typical equity cyclicality.

This fund suits investors with a long-term horizon of 5-7 years or more who want a value-contrarian approach with lower volatility than the broad market, given its sub-0.9 beta and strong downside capture. It is appropriate for moderate risk tolerance investors who can withstand multi-year drawdowns and recovery periods. It works well as a core or diversifying holding within an equity allocation, particularly for SIP investors seeking steady long-term compounding.

• Consistent positive alpha over NIFTY 50 across all periods, including 9.36% over 5 years and 11.42% over 7 years
• Defensive profile with downside capture of 75-83% and beta below 0.9, cushioning market corrections
• Highly diversified 81-stock portfolio with no single holding above 4.8% of NAV

• SIP XIRR slightly trails category averages over 5, 7, and 10 year horizons
• Maximum drawdown duration of 790 days with a 254-day recovery, plus six drawdown events exceeding 10%, implies prolonged underwater periods